WednesdayDec 14, 2022 10:30 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Anchors Focus and Priority on Berubicin Clinical Development for GBM Treatment

John Climaco, CNS’s CEO, has lauded the company’s progress in Q3 2022, noting the successful expansion of its pivotal Berubicin trial into Europe within the quarter The company hopes to address the unmet need associated with GBM treatment with its lead drug candidate, Berubicin, trusting that the expansion into Europe will be integral to achieving interim analysis by mid-2023 CNS looks to build on the successful patient enrollment and dosing in France, which brings its operational tally to 29 of 68 clinical sites enrolling patients across the United States and Europe, as it works toward interim analysis of clinical trials…

Continue Reading

WednesdayDec 14, 2022 9:45 am

Cepton, Inc. (NASDAQ: CPTN) Remains Committed to Improving Road Safety Through Development of Lidar Solutions for Assisted and Autonomous Driving

Nearly all automotive OEMs have plans to include lidar sensors within their assisted and automated driving platforms Gaining public trust in the ability of vehicles to operate safely while providing automated driving features will be a key milestone for widespread adoption L2+/L3 ADAS is likely to be an enabler as it helps ease the public with broader hands-free functions while maintaining the ability to take over as needed Cepton’s lidar sensors are uniquely positioned to benefit from these core industry growth trends and the Company remains committed to delivering superior driving experiences with added safety and convenience Automotive OEMs have…

Continue Reading

WednesdayDec 14, 2022 9:00 am

Cerberus Cyber Sentinel Corp. (NASDAQ: CISO) Offers Solutions for Smart Businesses to Keep Making Cybersecurity a Priority

Cost-cutting becomes a priority for businesses looking to remain strong during record inflation “It’s always a question of what to prioritize and which costs to minimize while preserving the quality of your product,” states a Forbes article Cerberus ensures that companies not only stay more secure but also build a culture of cybersecurity In a fragile economy with a possible recession looming on the horizon, savvy companies are taking a close look at ways to tighten their belts. As they do so, a recent Forbes article cautions wise business leaders to keep cybersecurity in the forefront (https://ibn.fm/ui99g), a strategy that…

Continue Reading

TuesdayDec 13, 2022 2:52 pm

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Featured in ‘Stock2Me’ Podcast

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, was featured in the latest episode of the Stock2Me Podcast, an IBN solution to provide specialized content distribution via widespread syndication channels. BiondVax’s CEO Amir Reichman joined the latest episode to introduce the company and discuss its recent development efforts focused on innovative nanosized antibody (“NanoAb”) therapies addressing diseases underserved by current treatments and with large and growing markets. “[While attempting to develop the universal influenza vaccine], BiondVax built a state-of-the-art facility in Jerusalem. It’s a…

Continue Reading

TuesdayDec 13, 2022 2:39 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Secures Largest Contract in Its History

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, today announced the largest single contract in the company’s history alongside two new contracts from cities in New York and Georgia. Under the contracts, Knightscope will deploy 12 K5 Autonomous Security Robots (“ASRs”), 2 K1 Blue Light Towers and 2 K1 Call Boxes. The announcement reads, “A key decision-making factor for the larger client was the K5’s unmatched capabilities that are not part of the current security program. The company will be deploying ASRs as part of an overall ‘layered’ approach to give them unprecedented eye-level views and coverage. The…

Continue Reading

TuesdayDec 13, 2022 12:01 pm

QualityStocksNewsBreaks – SideChannel Inc. (SDCH) CEO Talks TikTok as National Security Threat on Fox Business’ “Mornings with Maria”

SideChannel Inc. (OTCQB: SDCH) CEO Brian Haugli was a guest on “Mornings with Maria,” a Fox Business program that features industry titans and economic experts discussing the major news and themes driving the business day and the market moves. Haugli discussed rising concerns that TikTok, an application owned by China-based DanceByte, presents a national security issue. Those concerns have been fueled by GOP leaders calling for the application to be banned and the FBI issuing a statement about the possibility that the Chinese government could use the app to control data collection on millions of users, control the recommendation algorithm or…

Continue Reading

TuesdayDec 13, 2022 12:00 pm

Coyuchi Inc. Offers Gold Standard Luxury Home Goods to Satisfy Growing Market of Sustainability-Conscious Consumers

66% of US consumers (80% of consumers aged 18-34) are willing to pay more for products made with sustainability in mind The luxury home décor market is expected to reach $207 billion by 2027, growing from $118 billion in 2020 at a CAGR of 5.14% Coyuchi guarantees the highest environmental and ethical standards through its certifications - The Global Organic Textile Standard (“GOTS”), Fair Trade Certified, and MADE SAFE(R) Coyuchi is built upon four foundational pillars – protecting the environment, innovating circular design, living sustainably, and enriching the community – with over 1400 SKUs made from 100% organic cotton The…

Continue Reading

TuesdayDec 13, 2022 11:52 am

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Signs RMA as First US Dealer Partner for Commercial EV Lineup

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced Randy Marion Automotive (“RMA”) as the first dealer group partner for MULN’s commercial EV lineup, which is set to launch in the U.S. in 2023. The commercial EV line includes Class 1-3 cargo van and cab chassis offerings and Bollinger Motors Class 4-6 chassis products. “We are impressed with Mullen Automotive’s EV lineup, their speed to market and, most notably, their focus on an underserved commercial market for EV vehicles,” said Randy Marion, CEO and founder of RMA. “This is especially obvious when you consider what has taken…

Continue Reading

TuesdayDec 13, 2022 11:15 am

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) Unveils Commercial Prototype of its ZVS Inverter Technology

Hillcrest Energy Technologies recently unveiled a commercial prototype of its 800-volt, 250-kilowatt Zero Voltage Switching (“ZVS”) traction inverter The production of a commercial prototype comes only months after the company had published white papers, extolling the potential of their revolutionary technology The inverter will be developed and integrated alongside Hillcrest’s partners, Hercules Electric Mobility as well as a separate Tier 1 automotive supplier The company envisions its inverter technology being deployed with batteries, electric motors, generators, fuel cells and any other power source requiring power conversion Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF), a clean technology company focused on developing…

Continue Reading

TuesdayDec 13, 2022 10:30 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) 2022 Calendar Year in Review

Lexaria Bioscience is a global innovator in drug delivery platforms whose patented DehydraTECH(TM) technology has demonstrated the ability to improve the bioavailability and increase the speed of onset of many drugs In calendar 2022, the company achieved a number of milestones in various areas, including research programs, receipt of patents, and licensing agreements Lexaria started and completed its fourth and most comprehensive hypertension study yet, investigating the capabilities of DehydraTECH-CBD, with the study showing that its formulation resulted in a sustained reduction in blood pressure over the study period (five weeks) The company has also started investigating DehydraTECH-CBD as a…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered